An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853
·
clinicaltrials.gov ↗
COMPLETED
Status
137
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis, Primary Progressive
Multiple Sclerosis, Secondary Progressive
Sponsor
LAPIX Therapeutics Inc.